Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...
Owning a basic set of tools provides freedom. Freedom to stop a leaking faucet without calling a plumber or a landlord.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback